News

Caladrius Biosciences (CLBS) NobleCon17 Presentation Replay

Health
0 min read

Caladrius Biosciences (CLBS) CEO David Mazzo at NobleCon17 – Noble Capital Markets 17th Annual Small & Microcap Investor Conference – January 2021. Following the formal presentation, Noble Capital Markets Senior Research Analyst Ahu Demir, PhD joins David to moderate a Q&A session.

NobleCon 17 Complete Rebroadcast

Share

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
© 2018-2024 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.